Losartan 1 A Pharma

Losartan potassium, the active ingredient in Losartan 1 A Pharma, is an angiotensin II receptor blocker presented as an oral tablet for systemic use. It is prescribed to manage high blood pressure and related cardiovascular conditions in adult patients.

GNH USA supplies Losartan 1 A Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide. The company adheres to EU quality standards and provides regulatory documentation for import.

Losartan is an angiotensin II receptor blocker used to treat conditions related to the renin‑angiotensin system.

- Hypertension: lowers blood pressure and reduces cardiovascular risk. - Heart failure: improves symptoms and decreases hospitalization rates. - Diabetic nephropathy: slows progression of kidney damage in patients with type 2 diabetes. - Stroke risk reduction: lowers the chance of recurrent stroke in patients with prior cerebrovascular events.

Losartan may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue - Upper respiratory tract infection - Diarrhea

Serious or Rare Side Effects: - Hyperkalemia: elevated blood potassium levels - Angio‑edema: swelling of face, lips, tongue or throat - Acute kidney injury: sudden decline in renal function

When prescribing Losartan, clinicians should consider several safety considerations.

- Renal function: assess baseline creatinine and eGFR before initiation. - Electrolytes: monitor serum potassium periodically, especially with concomitant potassium‑sparing agents. - Volume status: avoid use in patients with severe dehydration or volume depletion. - Concomitant NSAIDs: use cautiously as they may reduce antihypertensive effect and impair renal function. - Pregnancy: discontinue if pregnancy is confirmed; drug is contraindicated in the second and third trimesters. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Losartan can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Aliskiren: combined use in diabetic patients is contraindicated due to increased risk of renal impairment, hyperkalemia and hypotension. - Potassium supplements or potassium‑sparing diuretics: may cause dangerous hyperkalemia.

Moderate Interactions (Monitor Closely): - NSAIDs (e.g., ibuprofen): may blunt antihypertensive effect and worsen renal function. - Lithium: concurrent use can increase lithium levels, risking toxicity. - ACE inhibitors or other ARBs: additive blood pressure lowering and hyperkalemia risk; avoid simultaneous use.